NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
BLOODO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/20/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 10, 44
Filing date
11/24/2022
Registration date
05/20/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
16
Owner location
Vilnius, LT
Examiner
GRYGIEL, JONATHAN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized light blue wording "BLOODO"; to the left of this appears a design of two droplets, being a light blue droplet above, which is cut in half so that only the right half appears in the design, and a red droplet below.
Holders and representatives
Holders
FUNDACIJA
Representatives
Nicholas D. Wells LEGENDS LAW GROUP, PLLC
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for medical usereagents for blood grouping; Test strips for measuring blood glucose levels; Chemical preparations for medical purposesfor testing blood to detect metabolic disorders and diagnose endocrine disorders
Class 10
Blood filters; Filters for blood and blood components for medical purposes; Apparatus for taking blood; Blood testing apparatus; Blood collection needles; Blood testing apparatusblood collection tubes for medical use; Blood lancets
Class 44
Medical testing of blood; Medical services relating to the removaltreatment and processing of human blood; Medical services relating to the removaltreatment and processing of umbilical cord blood; Therapy servicesnutritional therapy and cognitive-behavioral therapy (CBT); Endocrinology therapyproviding thyroid hormone (TTH) management medical services for hypothyroidismas well as estrogentestosteroneother hormone level monitoring and adjustment medical services; Pharmacotherapymedication management and optimization being medical services involving the incorporation of laboratory-based medical testing of HbA1c for diabetes managementNAD testing for determining optimal supplement dosagesfatty acid profiling for omega supplement recommendationsvitamin D level assessmentsalong with additional biomarkers being metabolicnutritionalhormonalinflammatorygeneticdetoxification markers measurable from human samples; Biofeedback therapyproviding medical information based on the analysis of various biomarkers being vitamin levelshormone levelsother measurable factors being metabolicinflammatorygeneticdetoxification markers; Gene therapygenetic testing to identify predispositions for genetic conditions or assess future disease risks for medical purposes; Herbal medicine therapyhealth assessment services regarding the effects of herbal remedies on biological markers being vitamin D levelsfatty acidsHbA1cbased on the analysis of various biomarkers being vitamin levelshormone levelsother measurable factors being metabolicinflammatorygeneticdetoxification markers to evaluate their efficacy; Medical and healthcare services; Health screening services in the field of metabolic disorders and endocrine disorders; Medical services; Professional consulting services in the field of healthcare
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/18/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/17/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/25/2024
GNFR
FINAL REFUSAL E-MAILED
11/25/2024
CNFR
FINAL REFUSAL WRITTEN
11/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/30/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/01/2024
GNRT
NON-FINAL ACTION E-MAILED
07/01/2024
CNRT
NON-FINAL ACTION WRITTEN
07/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2024
ALIE
ASSIGNED TO LIE
04/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/06/2023
GNRT
NON-FINAL ACTION E-MAILED
09/06/2023
CNRT
NON-FINAL ACTION WRITTEN
09/06/2023
DOCK
ASSIGNED TO EXAMINER
09/06/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/18/2022
NWAP
NEW APPLICATION ENTERED
11/28/2022
Continuous trademark protection
Get notified about every new filing that threatens BLOODO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.